UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...
A one-time injection of a novel gene therapy was able to save mice and a newborn calf from succumbing to maple syrup urine ...
Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...
“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...
The Phase 3 ARTEMIS trial (NCT06856577) is designed to evaluate the safety and efficacy of Ixo-vec in a randomized (1:1), double-masked, sham-controlled, two-arm study. The US-based trial is intended ...
22h
ExtremeTech on MSNGene Therapy Partially Restores Sight in Legally Blind ChildrenA promising study out of the United Kingdom has partially restored the vision of multiple small children born legally blind.
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...
Welcome to the BioLife Solutions Q4 2024 shareholder and analyst conference call. (Operator Instructions). As a reminder, today's call is being recorded. I would now like to turn the conference call ...
Cash Position: As of December 31, 2024, Fractyl had approximately $67.5 million in cash and cash equivalents. Based on ...
Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...
BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading provider of cell processing tools for the cell and gene therapy market, saw its shares jump 7.9% after reporting ...
The latest freezer and incubator technology aims to better preserve sample integrity and enable more physiologically-relevant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results